Related Experiment Videos
Pathogenetic basis of vascular dementia
1Department of Psychiatry and Neurochemistry, University of Göteborg, St. Jörgen's Hospital, Hisings, Backa, Sweden.
Alzheimer Disease and Associated Disorders
|January 1, 1991
Summary
Vascular dementia (VAD) may stem from subcortical white matter changes, not just brain infarcts. This study highlights myelin lipid decrease and blood-brain barrier dysfunction as key factors in VAD pathogenesis.
Area of Science:
- Neurology
- Neuroscience
- Pathology
Background:
- Vascular dementia (VAD) is often linked to brain infarcts and thromboembolism.
- The precise pathogenetic mechanisms underlying VAD require further elucidation.
- Existing diagnostic criteria for VAD involve dementia alongside cerebrovascular events.
Purpose of the Study:
- To investigate the pathogenetic aspects of Vascular dementia (VAD).
- To evaluate the role of brain infarcts versus other vascular pathologies in VAD.
- To identify alternative substrates contributing to VAD development.
Main Methods:
- Analysis of patients diagnosed with VAD based on dementia and vascular disease history.
- Utilized Computed Tomography (CT) to assess white matter lesions.
- Measured myelin lipid content and albumin ratio to assess blood-brain barrier (BBB) integrity.
Main Results:
- Frequent occurrence of CT white matter lesions (85%) in VAD patients.
- Pronounced decrease in myelin lipids observed in subcortical white matter.
- Increased albumin ratio indicated blood-brain barrier (BBB) dysfunction, independent of TIA/stroke.
- Brain infarcts appeared as endpoint manifestations, not primary causes.
Conclusions:
- Subcortical white matter changes, including myelin lipid reduction and BBB dysfunction, represent a significant VAD substrate.
- Findings challenge the sole reliance on thromboembolism and multiple cerebral infarcts (multi-infarct dementia) as the primary cause of VAD.
- Vascular dementia pathogenesis is likely multifactorial, involving white matter pathology beyond infarcts.